Sodium Pyruvate-1-¹³C: Isotope Tracing Protocol Guide

Sodium pyruvate-1-¹³C is a stable isotope-labeled form of sodium pyruvate in which the C-1 carbonyl carbon is enriched with carbon-13, enabling precise tracking of pyruvate metabolism through the TCA cycle, gluconeogenesis, and other central carbon metabolic pathways by NMR spectroscopy and mass spectrometry.

Product Name

Sodium pyruvate-1-¹³C

SKU

S345696

Labeled Position

C-1 (carbonyl carbon) enriched with ¹³C

Isotope

Carbon-13 (¹³C), stable, non-radioactive

Primary Applications

Metabolic flux analysis, ¹³C NMR, isotope tracing in cell culture and in vivo models

Storage Recommendation

Store at -20 °C, protect from moisture; prepare fresh aqueous solutions before use

Overview and Principle of ¹³C Isotope Tracing with Sodium Pyruvate-1-¹³C

Sodium pyruvate-1-¹³C (SKU: S345696) is a stable, non-radioactive isotopologue of sodium pyruvate bearing a ¹³C label specifically at the C-1 carbonyl carbon. Because ¹³C is a spin-½ nucleus detectable by NMR and produces a mass shift of +1 Da detectable by mass spectrometry, this compound serves as a powerful metabolic tracer.

Pyruvate occupies a pivotal node in central carbon metabolism: it is the end-product of glycolysis, a substrate for the TCA cycle (via pyruvate dehydrogenase, yielding acetyl-CoA), a precursor for gluconeogenesis (via pyruvate carboxylase), and a substrate for transamination (yielding alanine). When sodium pyruvate-1-¹³C is supplied to cells or to a living system, the fate of the C-1 label can be followed through these pathways to determine relative flux rates.

Critically, the C-1 carbonyl carbon of pyruvate is released as ¹³CO₂ by the pyruvate dehydrogenase reaction, whereas pyruvate carboxylase retains the C-1 label in oxaloacetate. This differential fate makes sodium pyruvate-1-¹³C particularly informative for distinguishing oxidative decarboxylation from anaplerotic carboxylation in metabolic studies.

Solution Preparation and Handling

Reagents and equipment required: Sodium pyruvate-1-¹³C (S345696), sterile water for injection or phosphate-buffered saline (PBS, pH 7.4), 0.2 µm syringe filter, analytical balance, volumetric glassware, and appropriate personal protective equipment (gloves, lab coat, eye protection).

Stock solution preparation:

1. Allow the sealed vial to equilibrate to room temperature before opening to minimise condensation-related degradation.
2. Weigh the required amount of Sodium pyruvate-1-¹³C using a calibrated analytical balance. The molecular weight of sodium pyruvate is 110.04 g/mol; for the ¹³C-labeled form, the molecular weight is approximately 111.03 g/mol (one ¹³C substitution at C-1).
3. Dissolve in sterile water or PBS to the desired concentration (commonly 100 mM for cell culture experiments). Sodium pyruvate is highly water-soluble; dissolution is typically rapid at room temperature.
4. Sterilise the solution by passage through a 0.2 µm filter into a pre-labelled, sterile container. Do not autoclave, as high temperatures promote pyruvate degradation.
5. Prepare fresh solutions on the day of use. If short-term storage is required, aliquot and store at -20 °C; avoid repeated freeze–thaw cycles.

Safety note: Sodium pyruvate-1-¹³C is a stable isotope compound and is not radioactive. Standard laboratory safety precautions apply. Consult the Safety Data Sheet (SDS) before use.

Cell Culture Isotope Tracing Protocol

This section describes a general protocol for ¹³C isotope tracing in mammalian cell culture using Sodium pyruvate-1-¹³C. Adapt conditions (cell line, duration, concentration) to your specific experimental system.

Protocol steps:

1. Cell preparation: Culture cells to 70–80% confluency in standard growth medium. Twenty-four hours before the tracing experiment, replace medium with tracer-free (unlabeled) equivalent medium to deplete endogenous pyruvate pools.
2. Tracer medium preparation: Prepare culture medium in which the standard (unlabeled) sodium pyruvate is replaced entirely by Sodium pyruvate-1-¹³C at the same molar concentration used in your standard medium (typically 1 mM for DMEM). Ensure all other medium components are identical to avoid confounding variables.
3. Tracer incubation: Aspirate existing medium, wash cells once with warm PBS, then add tracer medium. Incubate at 37 °C with 5% CO₂ for the desired labeling period. Common labeling periods range from 4–24 hours depending on the metabolic process under investigation; shorter periods are used to capture early labeling dynamics.
4. Quenching and metabolite extraction: At the end of the labeling period, rapidly aspirate medium, quench metabolism immediately by adding ice-cold extraction solvent (e.g., 80% methanol/water, -80 °C pre-chilled) directly to the plate. Scrape cells, transfer to microcentrifuge tubes, vortex, and centrifuge at 14,000 × g for 10 min at 4 °C. Collect the supernatant (metabolite extract).
5. Drying and resuspension: Dry the supernatant under a gentle nitrogen stream or using a vacuum concentrator. Resuspend in appropriate solvent for downstream analysis (e.g., LC-MS-grade water/acetonitrile for mass spectrometry; D₂O for NMR).
6. Analytical measurement: Analyse metabolite extracts by LC-MS/MS or GC-MS for isotopologue distribution analysis, or by ¹³C NMR spectroscopy. Measure the fractional enrichment of ¹³C in downstream metabolites (e.g., acetyl-CoA-derived citrate, oxaloacetate-derived malate, alanine) to infer metabolic flux.

Data Analysis: Isotopologue Distribution and Metabolic Flux Interpretation

After mass spectrometric or NMR acquisition, raw isotopologue data require correction and interpretation to yield biologically meaningful flux information.

Natural abundance correction: All raw mass spectrometry data must be corrected for the natural abundance of ¹³C (approximately 1.1% per carbon) and other isotopes using established algorithms (e.g., IsoCor, AccuCor, or equivalent software). Failure to apply this correction leads to overestimation of ¹³C enrichment.

Isotopologue notation: Metabolites are described as M+0 (fully unlabeled), M+1 (one ¹³C incorporated), M+2, etc. For sodium pyruvate-1-¹³C tracing, the key expected isotopologues and their metabolic interpretation are:

• Acetyl-CoA / Citrate M+0: Indicates flux through pyruvate dehydrogenase with loss of the C-1 label as ¹³CO₂ — consistent with oxidative decarboxylation.
• Oxaloacetate / Malate / Aspartate M+1: Indicates flux through pyruvate carboxylase retaining the ¹³C label at C-1 of oxaloacetate — consistent with anaplerosis.
• Alanine M+1: Indicates transamination of the labeled pyruvate by alanine aminotransferase.

Metabolic flux analysis (MFA): For quantitative flux determination, isotopologue distribution data can be integrated into isotopically non-stationary (INST-MFA) or steady-state MFA frameworks using software such as INCA, OpenMebius, or 13CFlux2. These tools fit measured isotopologue distributions to a stoichiometric metabolic network model to estimate absolute flux values.

Reporting: Report ¹³C fractional enrichment (molar fraction of each isotopologue), corrected for natural abundance, alongside cell number or protein content for normalisation. Include labeling duration and tracer concentration in all experimental reports.

Troubleshooting and Best Practices

The following guidance addresses common challenges encountered when working with Sodium pyruvate-1-¹³C:

• Low or inconsistent ¹³C enrichment in downstream metabolites: Verify that standard (unlabeled) pyruvate has been completely removed from culture media and serum supplements. Fetal bovine serum (FBS) may contain trace amounts of pyruvate; dialysed FBS should be considered for stringent experiments. Confirm tracer concentration and labeling duration are appropriate for the metabolic pathway of interest.
• Pyruvate degradation in solution: Pyruvate is susceptible to non-enzymatic decarboxylation, particularly at elevated temperatures or alkaline pH. Always prepare fresh solutions and verify pH of the tracer medium before use. Do not store aqueous pyruvate solutions at room temperature for extended periods.
• High M+0 background: If M+0 remains unexpectedly high after natural abundance correction, consider extending the labeling period or increasing tracer concentration. Also verify that natural abundance correction algorithms are being applied correctly.
• Isotopologue signal too low for NMR detection: ¹³C NMR is inherently less sensitive than ¹H NMR. For NMR-based experiments, use higher cell numbers, larger culture volumes, or longer labeling durations. Consider polarisation transfer experiments (DEPT, HSQC) to improve sensitivity.
• Contamination of ¹³C signal by unlabeled carbon sources: Ensure that all carbon-containing components of the medium (glucose, glutamine, fatty acids in serum) are accounted for in the experimental design. When possible, use uniformly ¹³C-depleted (¹²C-enriched) versions of other carbon sources to maximise tracer signal-to-noise.

Frequently asked questions

What is the metabolic significance of labeling pyruvate specifically at the C-1 position?

The C-1 carbonyl carbon of pyruvate has a distinct metabolic fate compared to C-2 and C-3. It is selectively lost as CO₂ by pyruvate dehydrogenase (oxidative decarboxylation) but retained in oxaloacetate by pyruvate carboxylase (anaplerosis). This positional selectivity allows researchers to distinguish between these two major pyruvate-consuming fluxes within the same experiment using ¹³C NMR or mass spectrometry.

Can Sodium pyruvate-1-¹³C be used in combination with other isotope tracers?

Yes, sodium pyruvate-1-¹³C can be used in parallel or sequential tracing experiments alongside other stable isotope tracers such as [U-¹³C₆]glucose or [U-¹³C₅]glutamine. However, simultaneous use of multiple ¹³C tracers complicates isotopologue deconvolution and requires advanced computational MFA tools. Deuterium (²H)-labeled tracers can be combined with ¹³C tracers more straightforwardly, as the mass shifts are orthogonal. Always design multi-tracer experiments carefully to avoid label overlap.

How should I calculate the concentration of Sodium pyruvate-1-¹³C for cell culture use?

Use the molecular weight of the ¹³C-labeled compound (approximately 111.03 g/mol, accounting for one ¹³C substitution at C-1 versus 110.04 g/mol for unlabeled sodium pyruvate) to prepare stock solutions. For example, to prepare a 100 mM stock solution, dissolve 11.10 mg of Sodium pyruvate-1-¹³C in 1 mL of sterile water. Dilute to working concentration (typically 1 mM in DMEM) in complete tracer medium. Always verify stock concentration by UV absorbance (pyruvate absorbs at approximately 320 nm) or by enzymatic assay if high accuracy is required.

Is Sodium pyruvate-1-¹³C radioactive, and what safety precautions are required?

Sodium pyruvate-1-¹³C is not radioactive. ¹³C is a stable isotope and poses no radiation hazard. Standard laboratory safety precautions apply, including the use of gloves, lab coat, and eye protection when handling the compound. Consult the Safety Data Sheet (SDS) provided by Aladdin Scientific for specific hazard classifications and disposal guidance.

What analytical platforms are compatible with Sodium pyruvate-1-¹³C tracing experiments?

Sodium pyruvate-1-¹³C is compatible with LC-MS/MS, GC-MS, and ¹³C NMR spectroscopy. LC-MS/MS and GC-MS offer high sensitivity and are well-suited for measuring isotopologue distributions in complex metabolite mixtures. ¹³C NMR spectroscopy provides direct positional information about the label distribution within individual metabolites but requires higher sample concentrations. The choice of platform depends on the metabolites of interest, required sensitivity, and available instrumentation.

References

1. Antoniewicz MR. Methods and advances in metabolic flux analysis: a mini-review. J Ind Microbiol Biotechnol. 2015;42(3):317-325. doi:10.1007/s10295-015-1585-x
2. Buescher JM, et al. A roadmap for interpreting ¹³C metabolite labeling patterns from cells. Curr Opin Biotechnol. 2015;34:189-201. doi:10.1016/j.copbio.2015.02.003
3. Jang C, Chen L, Rabinowitz JD. Metabolomics and Isotope Tracing. Cell. 2018;173(4):822-837. doi:10.1016/j.cell.2018.03.055
4. Vacanti NM, et al. Regulation of substrate utilization by the mitochondrial pyruvate carrier. Mol Cell. 2014;56(3):425-435. doi:10.1016/j.molcel.2014.09.024
5. Millard P, et al. IsoCor: correcting MS data in isotope labeling experiments. Bioinformatics. 2012;28(9):1294-1296. doi:10.1093/bioinformatics/bts127

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.